ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1367	National Cancer Institute	Html	en	Skin Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for skin cancer.	commonly occurring cancer 0.623357 skin cancer 0.936474 pediatric melanoma 0.671304 SCREEN study population 0.580579 skin awareness 0.580742 melanoma incidence rates 0.734128 observed modest mortality 0.599763 squamous cell cancers 0.595008 average annual incidence 0.632599 reduces melanoma mortality. 0.659883 health outcomes 0.587808 American Cancer Society 0.618195 important methodological limitations 0.577191 skin biopsy rates 0.677147 direct evidence 0.584321 nearly one-half 0.583908 two-stage skin cancer 0.6325 Medicare fee-for-service data 0.592604 U.S. cancer registries 0.618554 skin cancer screening 0.7411 melanoma 0.802792 UV radiation 0.57829 skin cancer awareness 0.703316 total-body visual examination 0.577539 vertical growth phase 0.58165	melanoma mortality rates 0.760008 reportable cancer 0.578136 End Results Program 0.589373 internal control group 0.578284 Basal cell carcinoma 0.600196 United States 0.662165 population-based skin cancer 0.635467 prolonged horizontal growth 0.582398 yearly incidence increase 0.63333 nonmelanoma skin cancers 0.683707 skin cancer. 0.5773 National Cancer Institute 0.614591 total number 0.59851 horizontal growth phase 0.661114 U.S. incidence rates 0.65648 main types 0.601467 initial pilot phase 0.579738 local disease 0.593927 skin lesions 0.583166 individual’s skin 0.577585 fewer melanoma death 0.654325 nonmelanoma skin cancer 0.723959 clinical visual screening 0.595993 SCREEN study 0.606378	CLICK HERE
1416	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	relapsed ovarian cancer 0.50784 recurrent epithelial ovarian 0.499159 ovarian cancer symptom 0.524517 gynecologic cancer intergroup 0.468129 epithelial ovarian carcinoma 0.585917 chemotherapy 0.476196 Engl J Med 0.538958 advanced ovarian cancer 0.684932 advanced epithelial ovarian 0.546935 ovarian cancer FIGO 0.514859 ovarian cancer. 0.501481 [PUBMED Abstract] 0.522867 primary peritoneal cancer 0.467281 ovarian cancer patients 0.574798 ovarian cancer trials 0.513542 Ovarian Cancer Registry 0.525648 ovarian cancer 0.976385 oncology group study 0.500359 advanced ovarian epithelial 0.508108 ovarian carcinoma 0.617715 Hereditary ovarian cancer 0.541701 Natl Cancer Inst 0.533435 Clin Cancer Res 0.471625 Gynecol Oncol 0.499118 ovarian carcinoma patients 0.50527	et al. 0.626141 gynecologic oncology group 0.583453 Lancet Oncol 0.480848 refractory ovarian cancer 0.508349 ovarian cancer—is 0.495704 ovarian cancers 0.496625 II-IV ovarian cancer 0.51385 advanced ovarian carcinoma 0.5343 ovarian epithelial cancer 0.539908 residual ovarian cancer 0.518325 epithelial ovarian cancer 0.803483 ovarian cancer susceptibility 0.533409 Brady MF 0.481715 sporadic ovarian cancer 0.521614 Abstract 0.644778 Clin Oncol 0.718243 platinum-sensitive ovarian cancer 0.536106 BRCA2-associated ovarian cancer 0.521842 recurrent ovarian cancer 0.527704 serous ovarian cancer 0.529665 Ovarian Neoplasm Group 0.493177 advanced-stage ovarian cancer 0.537713 ovarian cancer screening 0.523447 ovarian cancer syndrome 0.536708	CLICK HERE
1722	National Cancer Institute	Html	en	Head and Neck Cancers	A fact sheet about the risk factors, symptoms, diagnosis, treatment, follow-up, and rehabilitation for cancers of the head and neck.	Neck Cancer Epidemiology 0.558891 cancer treatment 0.49699 Fraumeni JF Jr. 0.515344 ongoing clinical trials 0.479834 squamous cell cancers 0.517935 nasopharyngeal cancer 0.510884 paranasal sinuses 0.510171 aerodigestive tract cancers 0.489416 Finding NCI-Supported Clinical 0.476958 American Cancer Society 0.489371 Cancer Treatment Research 0.487757 clinical trials 0.625013 Epstein-Barr virus 0.482033 neck cancer regions 0.574118 risk factors 0.503876 neck cancers 0.925546 PDQ® cancer treatment 0.487339 human papillomavirus 0.505881 HPV-positive oropharyngeal cancer 0.487463 Cancer Epidemiology Consortium 0.490318 United States 0.527186 primary cancer 0.487797 especially cancers 0.493827 Cancer fact sheet 0.485173	oropharyngeal cancers 0.540233 cancer information specialist 0.512175 Cancer Information Service 0.478534 neck squamous cell 0.508691 head 0.661624 neck primary site 0.509523 nci-supported clinical trials 0.526157 Oxford University Press 0.514213 National Cancer Institute 0.552506 neck area 0.499808 nasal cavity 0.508976 salivary glands 0.562893 risk factor 0.525252 Neck Surgery 0.494318 information specialist online 0.474123 cancer clinical trials 0.537911 salivary gland cancer 0.527021 neck cancer 0.711277 Clinical Cancer Research 0.481823 et al 0.678713 oral cavity 0.564891 salivary gland cancers 0.553898 oropharyngeal cancer 0.508219 oropharyngeal cancer incidence 0.479853	CLICK HERE
1821	National Cancer Institute	Html	es	Tratamiento de los tumores neuroendocrinos de páncreas (tumores de células de los islotes) (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores neuroendocrinos de páncreas (tumores de células de los islotes).	Compton CC 0.337256 Hepatic arterial embolization 0.325449 Palliative cytoreductive surgery 0.324641 Surg Oncol Clin 0.345323 Institute Neuroendocrine Tumor 0.318293 cases with 0.339293 cytoreductive surgery versus 0.325381 Zee S 0.32021 from neuroendocrine tumors 0.335775 Curr Gastroenterol Rep 0.341683 metastatic pancreatic 0.328587 Sharma D 0.340566 7th ed 0.33713 neuroendocrine tumors after 0.325028 pancreatic endocrine neoplasms 0.343793 Pract Res Clin 0.325267 Prognostic factors 0.322876 Arch Surg 0.319413 Kulke MH 0.322635 peripancreatic neuroendocrine tumors 0.33552 patients with 0.809404 Davies K 0.320348 Database Syst Rev 0.362811 Conlon KC 0.392512 metastases from 0.336216	neuroendocrine tumors 0.991054 Cancer Institute Neuroendocrine 0.319181 Liver resection versus 0.326125 unresectable neuroendocrine hepatic 0.331365 neuroendocrine tumors uncontrolled 0.335147 Gurusamy KS 0.342295 Cancer Staging Manual 0.396035 tumores neuroendocrinos 0.382461 National Cancer Institute 0.337396 neuroendocrine tumours 0.357049 Radioembolization with 0.325231 Yao JC 0.326134 using resin 90Y-microspheres 0.325276 Kwekkeboom DJ 0.325065 New York 0.332728 internal radiation microspheres 0.324552 Clin Oncol 0.662006 Gastrointest Surg 0.319657 Hochwald SN 0.321828 Byrd DR 0.335399 pancreatic neuroendocrine tumors 0.490395 with pancreatic 0.327776 Res Clin Gastroenterol 0.325221 AJCC Cancer Staging 0.3987	CLICK HERE
1900	National Cancer Institute	Html	es	Tratamiento del cáncer de cuello uterino (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de cuello uterino.	siguientes procedimientos 0.302623 Estadios llB 0.300134 estadios lB1 0.300176 estadios ia 0.300186 estadio ivb 0.3015 cuello uterino.El estadio 0.301223 estadio iva 0.301104 proteína llamada factor 0.30017 estadios iiia 0.300186 recto.El cáncer 0.301048 áreas anormales.ampliar examen 0.300205 Instituto Nacional 0.300194 Cervical Cancer 0.300274 Drugs Approved 0.300299 pared pélvica.El cáncer 0.30107 medicamento des 0.300142 prueba pap 0.300163 principal factor 0.300454 siguientes estadios 0.300489 estadio lA1 0.300374 funcionar.El cáncer 0.301061 estadios iva 0.300174 prueba pap.ampliar 0.300132 pequeñas incisiones 0.30013 estadificación quirúrgica pretratamiento 0.300689	pequeña cantidad 0.300319 estadio ii 0.301571 estadio ia 0.301549 enlace drugs approved 0.300178 estadio ila 0.30036 realidad células 0.300277 estadio ia2 0.300842 cm.El estadio lB 0.300541 estadios iia 0.300188 estadio iiia 0.300822 PDQ Tratamiento 0.300222 estadio iia 0.300852 estadios ib1 0.300186 siguientes signos 0.300145 Physician Data Query 0.300387 Ampliar Cáncer 0.30485 siguientes causas 0.300199 lápiz mide 0.300224 estadio iii 0.301447 cuello uterino 0.99838 cono.La conización 0.30013 histerectomía abdominal 0.300165 estadio ib2 0.300835 siguientes sumarios 0.300269	CLICK HERE
1914	National Cancer Institute	Html	es	Tratamiento de los tumores del sistema nervioso central en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores del sistema nervioso central en adultos.	radiocirugía estereotáctica 0.512702 Organización Mundial 0.518554 gliomas mixtos 0.51602 Brain Tumors 0.505258 siguientes procedimientos 0.502302 adultos jóvenes 0.506123 siguientes aspectos 0.504348 faja ajustadora 0.507035 Turcot tipos 0.506804 siguientes afecciones 0.507417 carcinomas embrionarios 0.505469 células normales.ampliar exploración 0.504663 siguientes tipos 0.506796 rayos x 0.507888 Neurofibromatosis tipos 0.506813 encéfalo benignos 0.526234 enlace drugs approved 0.509464 carcinoma nevoide 0.505116	tumores benignos 0.543382 aparato explorador 0.50369 médula espinal.Tumores 0.528221 PDQ Tratamiento 0.597843 alta potencia 0.50285 tumores cerebrales 0.516865 saco vitelino 0.505401 siguientes factores 0.504592 sistema nervioso central 0.930279 menor daño 0.503236 cuerpo.ampliar exploración 0.504376 encéfalo.ampliar craneotomía 0.503787 von hippel-lindau 0.505069 tumores embrionarios 0.532834 cáncer.ampliar radioterapia 0.506826 radioterapia externa 3D 0.508073 radiocirugía estereotáxica 0.502266	CLICK HERE
1997	National Cancer Institute	Html	es	Tratamiento de los astrocitomas infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los astrocitomas infantiles.	high-grade astrocytoma 0.444609 BRAF mutation 0.44863 pontine gliomas 0.513199 brain tumors 0.449797 cerebellar astrocytomas 0.465185 astrocitomas pilocíticos 0.812488 Cancer Res 0.478751 thalamic gliomas from 0.475546 neurofibromatosis tipo 0.470126 pilocytic astrocytoma 0.928999 Children's Oncology Group 0.451226 optic-hypothalamic gliomas 0.471792 central nervous system 0.495263 gliomas reveals key 0.471536 h3f3a k27m mutation 0.438972 Nat Genet 0.454568 pediatric gliomas 0.555458 astrocitomas difusos).Recién 0.471123 Glioma Treated with 0.441082 Acta Neuropathol 0.692887 Pediatric Pilocytic Astrocytomas 0.43879 mutación braf v600e 0.473181 Organización Mundial 0.468352 Salud Grado 0.453036 Metastatic Low-Grade Gliomas 0.479197	braf v600e mutation 0.454684 astrocitomas infantiles grupo 0.489856 vía óptica 0.453436 Neuro Oncol 0.501948 BRAF V600E 0.638339 low-grade glioma 0.976552 Pediatr Blood Cancer 0.686119 gliomas with braf 0.498818 low-grade astrocytomas 0.452781 fusión braf-kiaa1549 0.457715 childhood low-grade glioma 0.438409 optic pathway glioma 0.455238 mutaciones braf v600e 0.497547 diffuse high-grade astrocytomas 0.440868 malignant gliomas arising 0.476149 Clin Oncol 0.452652 nervous system tumors 0.44069 sistema nervioso central 0.547399 gliomas identifies recurrent 0.476033 mutaciones braf 0.520493 mutaciones puntuales braf 0.489841 Saluda Tipo Grado 0.458304 presuntos gliomas 0.491024 Neuropathol Exp Neurol 0.51285	CLICK HERE
3428	National Cancer Institute	Html	es	Terapia fotodinámica para el cáncer	Hoja informativa que explica en qué consiste la terapia fotodinámica, cómo se administra y las indicaciones y los efectos secundarios del tratamiento.	Molecular Biology 0.32441 photodynamic therapy 0.633479 photodynamic treatment 0.328771 Henderson BW 0.324256 Drug Administration 0.328891 causa efectos 0.325407 sustancia fotosensiblizadora 0.344827 Fukumura D 0.324644 Dongen GA 0.325062 Jain RK 0.326105 multidrug-resistant tumors 0.324624 porfímero sódico 0.914711 Snow GB 0.3246 luz solar 0.46733 sustancia fotosensibilizadora 0.526993	vías respiratorias 0.328731 Biomedical Science 0.324903 Dougherty TJ 0.324729 determinados tipos 0.331782 Reviews Cancer 0.32893 cabo estudios 0.366968 cuello uterino 0.325997 Capella LS 0.324402 PubMed Abstract 0.802286 medicamento fotosensibilizador 0.406789 Cancer Institute 0.326562 Pottier RH 0.324615 Visser GW 0.325175 Goyan RL 0.324518	CLICK HERE
3445	National Cancer Institute	Html	es	Exámenes de detección del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de cavidad oral y orofaringe.	área pequeña detrás 0.683574 tratamiento causa efectos 0.644315 siguientes procedimientos 0.606927 Visuals Online 0.549544 PDQ Exámenes 0.703056 Physician Data Query 0.843474 prevención revisa 0.561244 siguientes tejidos 0.858513	PDQ Prevención 0.768143 cánceres ayuda 0.626832 información ayuda 0.565771 National Cancer Institute 0.586864 cáncer quizás 0.965609 siguientes riesgos 0.571803 siguientes sumarios 0.718231 Instituto Nacional 0.660842	CLICK HERE
3524	National Cancer Institute	Html	null	Planning for the Future—How NCI Gives Cancer Survivors Hope for a Family	NCI Story of Discovery portrays how fertility preservation research aids cancer survivors and supports families.			CLICK HERE